With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain ...

Health researchers working with DENT Neurologic Institute, Jamaica pharmaceutical company to increase global clinical research.

In the world of sports and fitness, recovery is just as important as performance. Whether you’re a professional athlete or a ...

A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called ...

Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...

A Jacobs School of Medicine and Biomedical Sciences researcher has received National Institutes of Health funding to gain better understanding of the neural mechanisms underpinning drug-mediated ...

A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...

Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...

A drug called buprenorphine may be the best tool doctors have to fight the fentanyl crisis. Why hasn’t it been more widely ...

CBD and THC bind to the same receptors but work differently. THC can cause memory loss and nausea, while CBD balances the ...

Scientists reveal how CBD could help ease chronic pain, anxiety, and mood disorders. Researchers have uncovered a potential ...

New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.